A cell-based multiplex immunoassay platform using fluorescent protein-barcoded reporter cell lines

Shengli Song1, Miriam Manook2, Jean Kwun2

  • 1Department of Immunology, Duke University School of Medicine, Durham, North Carolina, USA.

Communications Biology
|November 26, 2021
PubMed

Insights

Researchers developed stable, fluorescent protein-barcoded reporter cell lines for multiplex antibody screening against membrane proteins. This new cell-based platform enables high-throughput antibody discovery and immune characterization.

Area of Science:

  • Biotechnology
  • Immunology
  • Cell Biology

Background:

  • Multiplex immunoassays commonly use acellular antigens on solid-phase platforms like Luminex technology.
  • Cell barcoding with fluorescent dyes allows multiplex cell-based assays but involves complex labeling and quality control steps.
  • A need exists for a more streamlined approach to multiplex screening of antibodies targeting membrane proteins.

Purpose of the Study:

  • To develop and validate a novel cell-based platform using stable, fluorescent protein-barcoded reporter cell lines for multiplex antibody screening.
  • To enable high-throughput characterization of immune responses and discovery of antibodies against membrane-associated proteins.

Main Methods:

  • Generation of stable reporter cell lines engineered with fluorescent proteins for multiplexing.
  • Utilizing flow cytometry for deconvolution of barcoded cell panels.
  • Testing the system with cell panels expressing influenza A hemagglutinin trimers, human CCR2, and CCR5 proteins, including epitope-defined mutants.

Main Results:

  • Successful generation of stable, fluorescent protein-barcoded reporter cell lines.
  • Demonstrated utility of the cell-based system for multiplex screening via flow cytometry deconvolution.
  • Validated the platform with diverse membrane proteins, including viral and human targets, and their mutants.

Conclusions:

  • The developed fluorescent protein-barcoded reporter cell line system offers a robust and efficient platform for multiplex antibody screening.
  • This technology has the potential for 256-plex cell panels, significantly advancing antibody discovery and immune profiling for membrane proteins.

Related Concept Videos